PHAT Q1 2021 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$125,000

Operating Income

-$34M

Net Income

-$35M

EPS (Diluted)

$-0.96

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$50M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$246M

Total Liabilities

$82M

Stockholders' Equity

$164M

Cash & Equivalents

$238M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$125,000	$0	—
Operating Income	-$34M	-$20M	-64.8%
Net Income	-$35M	-$20M	-73.0%